Literature DB >> 9893626

Cancer genetic clinics: why do women who already have cancer attend?

C Julian-Reynier1, F Eisinger, F Chabal, Y Aurran, Y J Bignon, C Noguès, M Machelard, C Maugard, P Vennin, H Sobol.   

Abstract

Cancer patients attend oncogenetic clinics so that the existence of a genetic risk can be checked and the relatives informed. The aim of this study was to describe the expectations of cancer patients about genetic counselling and their beliefs about the aetiology of their disease. A survey based on self-administered questionnaires before and after the consultation was carried out on 115 women with breast/ovarian cancer who attended one of the six French participating clinics. In 59 cases (51%), the consultees' expectations focused on the preventive options available and in 86 cases (75%) on their offspring; 87 (76%) found the consultation informative. On average, the women rated heredity and diet as lower risk factors (P < 0.05) after the consultation than before. Heredity, stress and the environment were thought to be more decisive than diet, smoking and alcohol. 34 patients who seemed unlikely to have a genetic risk in the consultant's opinion thought heredity to be less relevant (P < 0.05) after the consultation than before. At the time of the survey, cancer patients accounted for at least half of the consultees attending oncogenetic clinics in France. They need to have the clinical specificities of their disease and its medical management explained. They attend mainly for their offspring's sake, whereas healthy clients attend for their own sake.

Entities:  

Mesh:

Year:  1998        PMID: 9893626     DOI: 10.1016/s0959-8049(98)00164-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

Review 1.  How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review.

Authors:  Stephanie Sivell; Glyn Elwyn; Clara L Gaff; Angus J Clarke; Rachel Iredale; Chris Shaw; Joanna Dundon; Hazel Thornton; Adrian Edwards
Journal:  J Genet Couns       Date:  2007-10-30       Impact factor: 2.537

2.  Does and should breast cancer genetic counselling include lifestyle advice?

Authors:  Akke Albada; Madelèn Vernooij; Liesbeth van Osch; Anouk Pijpe; Sandra van Dulmen; Margreet G E M Ausems
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

3.  Use and evaluation of an individually tailored website for counselees prior to breast cancer genetic counseling.

Authors:  Akke Albada; Margreet G E M Ausems; Roel Otten; Jozien M Bensing; Sandra van Dulmen
Journal:  J Cancer Educ       Date:  2011-12       Impact factor: 2.037

4.  A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling.

Authors:  Akke Albada; Sandra van Dulmen; Dick Lindhout; Jozien M Bensing; Margreet G E M Ausems
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

5.  A survey of patients' experiences with the cancer genetic counseling process: recommendations for cancer genetics programs.

Authors:  Dana T Kausmeyer; Eugene J Lengerich; Brenda C Kluhsman; Dorothy Morrone; Gregory R Harper; Maria J Baker
Journal:  J Genet Couns       Date:  2006-12       Impact factor: 2.537

6.  Experiences and interpretations of BRCA1/2 testing among women affected by breast or ovarian cancer who received a negative result.

Authors:  Lesley Stafford; Alison Flehr; Fiona Judd; Geoffrey J Lindeman; Penny Gibson; Angela Komiti; G Bruce Mann; Maira Kentwell
Journal:  J Community Genet       Date:  2019-03-27

7.  An assessment of genetic counseling services for individuals with multiple sclerosis.

Authors:  Stephanie Skinner; Colleen Guimond; Rachel Butler; Emily Dwosh; Anthony L Traboulsee; A Dessa Sadovnick
Journal:  J Genet Couns       Date:  2014-07-05       Impact factor: 2.537

8.  The importance of written information packages in support of case-finding within families at risk for inherited high cholesterol.

Authors:  Hélène W P van den Nieuwenhoff; Ilse Mesters; Joyce J T M Nellissen; Anton F Stalenhoef; Nanne K de Vries
Journal:  J Genet Couns       Date:  2006-02       Impact factor: 2.537

9.  Analysis of patient reports on the referral process to two NSW cancer genetic services.

Authors:  Grace I Butel-Simoes; Allan D Spigelman
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

10.  Acceptance of genetic counseling and testing in a hospital-based series of patients with gynecological cancer.

Authors:  Nicky Dekker; Eleonora B L van Dorst; Rob B van der Luijt; Marielle E van Gijn; Marc van Tuil; Johan A Offerhaus; Margreet G E M Ausems
Journal:  J Genet Couns       Date:  2012-11-30       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.